David Annis
Chief Tech/Sci/R&D Officer bij AILERON THERAPEUTICS, INC.
Vermogen: 1 862 $ op 29-02-2024
Profiel
David Allen Annis is Senior Vice President-Research at Aileron Therapeutics, Inc.
In his past career Dr. Annis held the position of Vice President-New Technologies at NeoGenesis Pharmaceuticals, Inc. and Director-Technology Development at Schering-Plough Research Institute.
Dr. Annis received an undergraduate degree from Georgia Institute of Technology and a doctorate and a graduate degree from Harvard University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
30-11-2023 | 377 ( 0.01% ) | 1 862 $ | 29-02-2024 |
Actieve functies van David Annis
Bedrijven | Functie | Begin |
---|---|---|
AILERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05-11-2018 |
Eerdere bekende functies van David Annis
Bedrijven | Functie | Einde |
---|---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Corporate Officer/Principal | - |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Opleiding van David Annis
Harvard University | Doctorate Degree |
Georgia Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AILERON THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |